Compounds > ly 353381
Page last updated: 2024-09-05

ly 353381 and bazedoxifene

ly 353381 has been researched along with bazedoxifene in 5 studies

Compound Research Comparison

Studies
(ly 353381)		Trials
(ly 353381)		Recent Studies (post-2010)
(ly 353381)		Studies
(bazedoxifene)		Trials
(bazedoxifene)		Recent Studies (post-2010) (bazedoxifene)
70121530769249

Protein Interaction Comparison

ProteinTaxonomyly 353381 (IC50)bazedoxifene (IC50)
Estrogen receptorHomo sapiens (human)0.0091
Replicase polyprotein 1abSevere acute respiratory syndrome coronavirus 23.44
Estrogen receptor betaHomo sapiens (human)0.0444

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohta, H1
Lewiecki, EM1
Silverman, SL1
Chines, AA; Komm, BS1
Calaf Alsina, J; Coronado Martín, PJ1

Reviews

5 review(s) available for ly 353381 and bazedoxifene

ArticleYear
[Status of novel bone-targeting SERMs in development].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Nov-28, Volume: 65 Suppl 9

    Topics: Animals; Bone and Bones; Bone Density; Clinical Trials as Topic; Drug Design; Humans; Indoles; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Rats; Receptors, Estrogen; Research; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Thiophenes

2007
Current and emerging pharmacologic therapies for the management of postmenopausal osteoporosis.
    Journal of women's health (2002), 2009, Volume: 18, Issue:10

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Denosumab; Drug Therapy, Combination; Female; Humans; Indoles; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Piperidines; Postmenopause; Pyrrolidines; Raloxifene Hydrochloride; RANK Ligand; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Vitamin D; Women's Health

2009
New selective estrogen receptor modulators (SERMs) in development.
    Current osteoporosis reports, 2010, Volume: 8, Issue:3

    Topics: Bone Density Conservation Agents; Breast Neoplasms; Female; Humans; Indoles; Osteoporosis; Piperidines; Pyrrolidines; Risk Factors; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Thiophenes

2010
An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis.
    Maturitas, 2012, Volume: 71, Issue:3

    Topics: Bone Density Conservation Agents; Breast; Endometrium; Female; Fractures, Bone; Humans; Indoles; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes

2012
[Third generation selective estrogen receptor modulators: benefits beyond bone. II, endometrial action].
    Medicina clinica, 2013, Mar-16, Volume: 140, Issue:6

    Topics: Adenocarcinoma; Animals; Breast Neoplasms; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation, Preclinical; Endometrial Neoplasms; Endometrium; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Indoles; Menopause; Multicenter Studies as Topic; Organ Specificity; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Rats; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes; Thromboembolism

2013